The Yin and Yang of CD4 + regulatory T cells in autoimmunity and cancer

Current Medicinal Chemistry

Volumn 16, Issue 35, 2009, Pages 4626-4631

  Galgani, M ^a   Di Giacomo, A ^b   Matarese, G ^c   La Cava, A ^d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b MONALDI HOSPITAL   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLOOXYGENASE 2; CYTOKINE; GALECTIN 1; INTERLEUKIN 2 RECEPTOR ALPHA; TRANSCRIPTION FACTOR FOXP3;

AUTOIMMUNITY; CANCER GROWTH; CANCER INHIBITION; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IMMUNOREGULATION; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR MECHANICS; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW;

AUTOIMMUNITY; CD8-POSITIVE T-LYMPHOCYTES; FORKHEAD TRANSCRIPTION FACTORS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 72449153982     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986709789878201     Document Type: Review

References (67)

1. Mackaness, G. Cellular resistance to infection. J. Exp. Med., 1962, 116, 381-406.
2. Gershon, R.K.; Kondo, K. Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology, 1970, 18, 723-737.
3. Gershon, R.K.; Kondo, K. Infectious immunological tolerance. Immunology, 1971, 21, 903-914.
4. Zembala, M.; Asherson, G.L. Depression of the T cell phenomenon of contact sensitivity by T cells from unresponsive mice. Nature, 1973, 244, 227-228.
5. Bullock, W.W.; Katz, D.H.; Benacerraf, B. Induction of Tlymphocyte responses to a small molecular weight antigen. II. specific tolerance induced in azebenzenearsonate (ABA)-specific T cells in Guniea pigs by administration of low doses of an ABA conjugate of chloroacetyl tyrosine in incomplete Freund's adjuvant. J. Exp. Med., 1975, 142, 261-274.
6. Swierkosz, J.E.; Swanborg R.H. Suppressor cell control of unresponsiveness to experimental allergic encephalomyelitis. J. Immunol., 1975, 115, 631-633.
7. Liew, F.Y. Regulation of delayed-type hypersensitivity. I. T suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur. J. Immunol., 1977, 7, 714-718. (Pubitemid 8212997)
8. Liew, F.Y.; Russell, S.M. Delayed-type hypersensitivity to influenza virus. Induction of antigen-specific suppressor T cells for delayed-type hypersensitivity to hemagglutinin during influenza virus infection in mice. J. Exp. Med., 1980, 151, 799-814. (Pubitemid 10118520)
9. Liew, F.Y.; Hale, C.; Howard, J.G. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells. J. Immunol., 1982, 128, 1917-1922.
10. Schrier, R.D.; Ishioka, G.Y.; Pizer, L.I.; Moorhead, J.W. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells. J. Immunol., 1985, 134, 2889-2893.
11. Murphy, J.W. Effects of first-order Cryptococcus-specific T-suppressor cells on induction of cells responsible for delayed-type hypersensitivity. Infect. Immun., 1985, 48, 439-445.
12. Sakaguchi, S.; Sakaguchi, N.; Asano, M.; Itoh M.; Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 1995, 155, 1151-1164.
13. Hori, S.; Nomura, T.; Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science, 2003, 299, 1057-1061. (Pubitemid 36222930)
14. Nelson, B.H. IL-2, regulatory T cells, and tolerance. J. Immunol., 2004, 172, 3983-3988.
15. Kulkarni, A.B.; Huh, C.G.; Becker, D.; Geiser, A.; Lyght, M.; Flanders, K. C.; Roberts, A.B.; Sporn, M.B.; Ward, J.M.; Karlsson, S. Transforming growth factor β1 null mutation in mice causes excessive inflammatory response and early death. Proc. Natl. Acad. Sci. USA, 1993, 90, 770-774. (Pubitemid 23028947)
16. Fontenot, J.D., Rasmussen, J.P.; Gavin, M.A.; Rudensky, A.Y. A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol., 2005, 6, 1142-1151. (Pubitemid 41541792)
17. + regulatory T cells. Int. J. Clin. Exp. Med., 2008, 1, 192-202.
18. Bettelli, E.; Carrier, Y.; Gao, W.; Korn, T.; Strom, T.B.; Oukka, M.; Weiner, H.L.; Kuchroo, V.K. Reciprocal developmental pathways for the generation of pathogenic effector Th17 and regulatory T cells. Nature, 2006, 441, 235-238.
19. + T regulatory cells. J. Exp. Med., 2004, 199, 323-335
20. + regulatory T cells are derived by rapid turnover of memory populations in vivo. J. Clin. Invest., 2006, 116, 2423-2433.
21. Sakaguchi, S. Regulatory T cells: key controllers of immunologic self-tolerance. Cell, 2000, 101, 455-458.
22. + suppressor T cells: more questions than answers. Nat. Rev. Immunol., 2002, 2, 389-400.
23. + T cells. Eur. J. Immunol., 2007, 37, 129-138
24. + regulatory T cells. Nat. Immunol., 2003, 4, 330-336.
25. Wildin, R.S.; Freitas, A. IPEX and FOXP3: clinical and research perspectives. J. Autoimmun., 2005, 25, S56-62.
26. Wildin, R.S.; Smyk-Pearson, S.; Filipovich, A. H. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome. J. Med. Gen., 2002, 39, 537-545.
27. Roncarolo, M.G.; Gregori, S.; Battaglia, M.; Bacchetta, R.; Fleischhauer, K.; Levings, M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol. Rev., 2006, 212, 28-50. (Pubitemid 44116698)
28. -!- secreting regulatory cells. Microbes Infect., 2001, 3, 947-954.
29. La Cava, A. Natural Tregs and autoimmunity. Front. Biosci., 2009, 14, 333-343.
30. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. J. Immunol., 1998, 160, 1212-1218.
31. low subset. J. Exp. Med., 172, 1990, 1701-1708.
32. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol., 1993, 5, 1461-1471.
33. high T cells in inflammatory bowel disease. Gastroenterology, 2005, 128, 1868-1878.
34. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med., 2004, 199, 971-979.
35. + regulatory T cells. Proc. Natl. Acad. Sci. USA, 2005, 102, 5150-5155.
36. + regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol., 2002, 169, 4712-4716.
37. + regulatory T cells during autoimmune diabetes. J. Exp. Med., 2005, 201, 1333-1346.
38. Gregori, S.; Giarratana, N.; Smiroldo, S.; Adorini, L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J. Immunol., 2003, 171, 4040-4047. (Pubitemid 37238678)
39. + regulatory T-cells contributes to the onset of autoimmune diabetes. Diabetes, 2008, 57, 113-123,
40. + T-cells from patients with type 1 diabetes. Diabetes, 2005, 54, 92-99.
41. + T cells contributes to diabetes pathogenesis in BB rats. J. Immunol., 2005, 174, 4081-4089.
42. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med., 2004, 199, 1467-1477.
43. Miyara, M.; Amoura, Z.; Parizot, C.; Badoual, C.; Dorgham, K.; Trad, S.; Nochy, D.; Debré, P.; Piette, J.C.; Gorochov, G. Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol., 2005, 175, 8392-8400. (Pubitemid 41798406)
44. Mellor-Pita, S.; Citores, M.J.; Castejon, R.; Tutor-Ureta, P.; Yebra-Bango, M.; Andreu, J.L.; Vargas, J.A. Decrease of regulatory T cells in patients with systemic lupus erythematosus. Ann. Rheum. Dis., 2006, 65, 553-554.
45. + regulatory T cells inhibit experimental anti-glomerular basement membrane glomerulonephritis in mice. J. Am. Soc. Nephrol., 2005, 16, 1360-1370.
46. high T regulatory cell function in patients with active systemic lupus erythematosus. J. Immunol., 2007, 178, 2579-2588.
47. Hahn, B.H.; Anderson, M.; Le, E.; La Cava, A. Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. Arthritis Rheum., 2008, 58, 2488-2497.
48. Scalapino, K.J.; Tang, Q.; Bluestone, J.A.; Bonyhadi, M.L.; Daikh, D.I. Suppression of disease in New Zealand Black/New Zealand White lupus-prone mice by adoptive transfer of ex vivo expanded regulatory T cells. J. Immunol., 2006, 177, 1451-1459.
49. high regulatory T cell population in peripheral blood. Rheumatology (Oxford), 2006, 45, 1210-1217.
50. + cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum., 2003, 48, 1452-1460.
51. + regulatory T cells. Arthritis Rheum., 2005, 52, 2212-2221.
52. + suppressors of delayed sensitivity precedes the production of suppressors of protective immunity. J. Exp. Med., 1986, 164, 1179-1192.
53. Liyanage, U.K.; Moore, T.T.; Joo, H.G.; Tanaka, Y.; Herrmann, V.; Doherty, G.; Drebin, J.A.; Strasberg, S.M.; Eberlein, T.J.; Goedegebuure, P.S.; Linehan, D.C. Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J. Immunol., 2002, 169, 2756-2761.
54. + T cells in tumors from patients with early-stage nonsmall cell lung cancer and late-stage ovarian cancer. Cancer Res., 2001, 61, 4766-4772.
55. Gobert, M.; Treilleux, I.; Bendriss-Vermare, N.; Bachelot, T.; Goddard-Leon, S.; Arfi, V.; Biota, C.; Doffin, A.C.; Durand, I.; Olive, D.; Perez, S.; Pasqual, N.; Faure, C.; Ray-Coquard, I.; Puisieux, A.; Caux, C.; Blay, J.Y.; Ménétrier-Caux, C. Regulatory T cells recruited through CCL22/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res., 2009, 69, 2000-2009.
56. Frumento, G.; Piazza, T.; Di Carlo, E.; Ferrini, S. Targeting tumor-related immunosuppression for cancer immunotherapy. Endocr. Metab. Immune Disord. Drug Targets, 2006, 6, 233-237. (Pubitemid 44383206)
57. + regulatory T cell proliferation. J. Exp. Med., 2005, 202, 919-929.
58. + T cells: a common basis between tumor immunity and autoimmunity J. Immunol., 1999, 163, 5211-5218.
59. + regulatory T cell in wild-type host. Proc. Natl. Acad. Sci. USA, 2005, 102, 9253-9257.
60. + regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur. J. Immunol., 2004, 34, 336-344.
61. + responder cells by Fas mediated apoptosis. J. Immunol,. 2009, 182, 1469-1480.
62. Sharma, M.D.; Baban, B.; Chandler, P.; Hou, D.Y.; Singh, N.; Yagita, H.; Azuma, M.; Blazar, B. R.; Mellor, A. L.; Munn, D. H. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest., 2007, 117, 2570-2582.
63. Bergmann, C.; Strauss, L.; Zeidler, R.; Lang, S.; Whiteside, T. L. Expansion of human T regulatory type 1 cells in the microenvironment of cyclooxygenase 2 overexpressing head and neck squamous cell carcinoma. Cancer Res., 2007, 67, 8865-8873. (Pubitemid 47437463)
64. Juszczynski, P.; Ouyang, J.; Monti, S.; Rodig, S.J.; Takeyama, K.; Abramson, J.; Chen, W.; Kutok, J.L.; Rabinovich, G.A.; Shipp, M.A. The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma. Proc. Natl. Acad. Sci. USA, 2007, 104, 13134-13139.
65. + T regulatory cells: role of tumor-derived TGF-β. J. Immunol., 2007, 178, 2883-2892.
66. + Tregs in lymphomas and tumors are complex. Front. Biosci. 2008, 13, 3986-4001.
67. Fountoulakis, S.; Vartholomatos, G.; Kolaitis, N.; Frillingos, S.; Philippou, G.; Tsatsoulis, A. HLA-DR expressing peripheral T regulatory cells in newly diagnosed patients with different forms of autoimmune thyroid disease. Thyroid, 2008, 18, 1195-1200.